Vision
My research group is dedicated to advancing cancer biodiagnostics and immunotherapy through four key research streams. We focus on multi-omic analyses to discover biomarkers and therapeutic targets, laying the foundation for precise interventions. My work in descriptive and predictive immunology harnesses high-throughput technologies to understand immune responses, crucial for personalizing treatments. We also employ single-cell and spatial proteogenomic technologies to delve into the complexities of the immune-cancer interaction, aiming to enhance immunotherapy outcomes. Finally, I leverage artificial intelligence in the design of mRNA therapeutics and vaccines, striving to create tailored solutions that integrate immune-modulatory elements for effective cancer treatment.
Collaborations
Javier Alfaro’s research in infectious disease and cancer biodiagnostics has led to meaningful collaborations worldwide. By integrating multi-omic data and AI-driven tools, his work has focused on developing precise diagnostic methods and personalized treatments. These international partnerships have facilitated the sharing of knowledge and resources, advancing the understanding of disease mechanisms and the development of mRNA therapies and vaccines. These efforts are helping to enhance the healthcare community’s capacity to address complex health challenges with innovative and accessible solutions.
Publications
A full list is available here.